Companies
Takeda Pharmaceutical
How Japan's oldest pharma company became a $30B global biopharma leader through the $62B Shire acquisition and a pipeline worth up to $20B
Keyword
How Japan's oldest pharma company became a $30B global biopharma leader through the $62B Shire acquisition and a pipeline worth up to $20B